Total Funding
37
Total FundingPost-IPO Equity raised
Growth Score in past quarter
pts
Heat Score 37 in past quarter
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
138914
Constellation Pharmaceuticals develops drugs in the field of epigenetics focusing on selective regulators of its function.
- Yang Shi: Co-Founder
- Danny Reinberg: Founder
About the Company
Constellation Pharmaceuticals is the first biopharmaceutical company dedicated to the development of novel therapeutics in the emerging field of Epigenetics, a new field of science which is focused on selective regulators of epigenetic function, which are critical to controlling gene expression.